V-Z

15mg Zenrelia for Dogs

15mg Zenrelia for Dogs is a prescription medicine used to help manage the itch and skin inflammation associated with allergic skin disease, including atopic dermatitis (atopy). Zenrelia is intended for dogs that have been examined by a veterinary surgeon and diagnosed with an allergic condition. Zenrelia 15mg is used as part of a wider care plan that may include parasite control, skin and ear care, environmental changes, and nutrition.

How Zenrelia for Dogs works

Zenrelia works by reducing the internal “itch signalling” between an allergen trigger and the urge to scratch. Ilunocitinib is a Janus kinase (JAK) inhibitor. JAK enzymes act like switches inside immune and skin cells, helping itch- and inflammation-related messenger proteins transmit their signals. By inhibiting JAK activity, Zenrelia dampens the effect of multiple cytokine signals associated with allergy and inflammation, so the skin receives fewer instructions to itch and inflame. This approach is different from an antihistamine, which blocks only histamine, and different from a corticosteroid, which broadly suppresses inflammation through multiple pathways. With 15mg Zenrelia, the aim is targeted interruption of the itch–scratch cycle so that rubbing and chewing decrease and the skin can start to recover. Because the medicine addresses signalling rather than simply masking the sensation, it can be useful in both allergic dermatitis and atopic dermatitis, where the itch is driven by immune messages as well as skin barrier weakness.

VETERINARY PRESCRIPTION REQUIRED

8.5mg Zenrelia for Dogs

8.5mg Zenrelia for Dogs is a prescription-only medication used to help manage the symptoms of atopic dermatitis in dogs (Atopy). Atopic dermatitis is a common, long-term skin condition that can significantly affect a dog’s comfort and overall wellbeing. Zenrelia is formulated to reduce the itching and inflammation that often accompany this condition, providing effective relief and improving quality of life.

Zenrelia contains an active ingredient that targets specific pathways in the immune system responsible for the itching and inflammation seen in atopic dermatitis. Unlike traditional anti-inflammatory drugs that act broadly, 8.5mg Zenrelia works by selectively blocking signals in the immune system that lead to the itch response.

When a dog with atopic dermatitis encounters an allergen, the immune system mistakenly identifies it as harmful and triggers a reaction. This process releases chemical messengers that cause the skin to itch and become inflamed. Zenrelia interferes with these signals, reducing the sensation of itching and calming the inflammation.

The 8.5mg strength is designed for small to medium-sized dogs and allows for accurate dosing according to weight. By interrupting the itch-scratch cycle, Zenrelia not only eases discomfort but also reduces the risk of further skin damage and secondary infections. Dogs that are less itchy are less likely to scratch and bite at their skin, which means healing can take place more effectively.

VETERINARY PRESCRIPTION REQUIRED

6.4mg Zenrelia is a once-daily, orally administered tablet containing ilunocitinib, a Janus kinase (JAK) inhibitor indicated for dogs from 12 months of age and weighing at least 3kg. It is formulated as a small, unflavoured film-coated tablet designed for ease of administration with or without food, with consistent dosing recommended at the same time each day.

Zenrelia works by inhibiting Janus kinase pathways involved in the inflammatory and pruritic signalling cascade. By targeting these pathways, Zenrelia reduces the biochemical processes that result in the characteristic itch and inflammation of allergic and atopic dermatitis. Following oral administration, it is rapidly absorbed, with visible improvements often appearing within 24 hours. While some dogs respond immediately, a full assessment of response should wait at least one week, with most showing notable improvement in itch and skin condition by two to four weeks.

Zenrelia 6.4mg is appropriate for use from the first veterinary consultation through diagnostic work-up and into long-term maintenance. Its simple, once-daily dosing implies that caregivers can begin treatment before a full diagnosis of atopic dermatitis, helping manage symptoms while underlying causes are explored and addressed.

VETERINARY PRESCRIPTION REQUIRED

Vetoryl 60mg Tablets are a veterinary medicine prescribed for the treatment of Cushing’s disease (also known as hyperadrenocorticism) in dogs. This chronic endocrine disorder affects the adrenal glands and leads to an overproduction of cortisol, a hormone involved in regulating metabolism, the immune system, and stress response.

60mg Vetoryl Tablets contain the active ingredient trilostane, which helps control this hormone imbalance. These tablets are designed to make daily dosing more practical and can be snapped in half to allow for accurate administration based on your dog’s weight and clinical needs.

Vetoryl 60mg tablets are prescription-only and should only be used under the supervision of a veterinary surgeon. Each Vetoryl 60mg tablet contains trilostane, a cortisol synthesis inhibitor. Trilostane works by blocking the activity of an enzyme involved in the production of cortisol within the adrenal glands. By reducing the output of cortisol, the medication helps control the effects of the disease and improve your dog’s clinical condition. These tablets are film-coated and scored, which allows them to be split in half easily. This is particularly useful for adjusting the dosage based on your vet’s recommendations. Vetoryl 60mg Tablets should be given with food, once daily, to improve absorption. Treatment with Vetoryl does not cure Cushing’s disease but manages its symptoms. Most dogs on the correct dose show noticeable improvement in energy levels, coat condition, appetite, and overall comfort within a few weeks of starting treatment.

VETERINARY PRESCRIPTION REQUIRED

30mg Vetoryl Tablets are used to treat hyperadrenocorticism, commonly known as Cushing’s disease, in dogs. Each 30mg Vetoryl Tablet contains 30mg of the active ingredient trilostane, a synthetic compound that helps regulate hormone production in the adrenal glands. Vetoryl is designed specifically for use in dogs and must only be given under the direction of a veterinary surgeon.

Vetoryl 30mg contains trilostane, a drug that inhibits an enzyme involved in the production of cortisol in the adrenal glands. By blocking this enzyme, trilostane reduces the amount of cortisol being produced. This helps to control the symptoms of Cushing’s disease and improves the dog’s quality of life. The 30mg dosage is one of several strengths available. It may be used on its own or in combination with other strengths to achieve the correct dose as prescribed by your veterinarian. Proper dosing is crucial and must be based on the dog’s weight, clinical condition, and response to treatment.

VETERINARY PRESCRIPTION REQUIRED

1.875mg Ypozane Tablets for Dogs are a prescription medication used primarily to treat benign prostatic hypertrophy (BPH) in male dogs. This condition involves the enlargement of the prostate gland, which can cause discomfort and other health issues. Ypozane contains the active ingredient osaterone acetate, which helps in managing and reducing the symptoms associated with this condition.

How Ypozane 1.875mg Tablets Work

Ypozane 1.875mg Tablets work by inhibiting the effects of testosterone on the prostate gland. Testosterone is a hormone that can contribute to the enlargement of the prostate gland in male dogs. By blocking the action of testosterone, osaterone acetate helps to reduce the size of the prostate, thereby alleviating the symptoms associated with BPH.

Treatment with Ypozane involves a simple, once-daily dose for seven days. This regimen has been shown to significantly reduce prostate volume within a short period. Studies have demonstrated that a 40% reduction in prostate size can be achieved within 14 days, with the therapeutic effects lasting for up to six months. This makes Ypozane for Dogs an effective and convenient solution for managing benign prostatic hypertrophy.

VETERINARY PRESCRIPTION REQUIRED

3.75mg Ypozane Tablets for Dogs are a prescription medication used primarily to treat benign prostatic hypertrophy (BPH) in male dogs. This condition involves the enlargement of the prostate gland, which can cause discomfort and other health issues. Ypozane contains the active ingredient osaterone acetate, which helps in managing and reducing the symptoms associated with this condition.

How Ypozane 3.75mg Tablets Work

Ypozane 3.75mg Tablets work by inhibiting the effects of testosterone on the prostate gland. Testosterone is a hormone that can contribute to the enlargement of the prostate gland in male dogs. By blocking the action of testosterone, osaterone acetate helps to reduce the size of the prostate, thereby alleviating the symptoms associated with BPH.

Treatment with Ypozane involves a simple, once-daily dose for seven days. This regimen has been shown to significantly reduce prostate volume within a short period. Studies have demonstrated that a 40% reduction in prostate size can be achieved within 14 days, with the therapeutic effects lasting for up to six months. This makes Ypozane for Dogs an effective and convenient solution for managing benign prostatic hypertrophy.

VETERINARY PRESCRIPTION REQUIRED

7.5mg Ypozane Tablets for Dogs are a prescription medication used primarily to treat benign prostatic hypertrophy (BPH) in male dogs. This condition involves the enlargement of the prostate gland, which can cause discomfort and other health issues. Ypozane contains the active ingredient osaterone acetate, which helps in managing and reducing the symptoms associated with this condition.

How Ypozane 7.5mg Tablets Work

Ypozane 7.5mg Tablets work by inhibiting the effects of testosterone on the prostate gland. Testosterone is a hormone that can contribute to the enlargement of the prostate gland in male dogs. By blocking the action of testosterone, osaterone acetate helps to reduce the size of the prostate, thereby alleviating the symptoms associated with BPH.

Treatment with Ypozane involves a simple, once-daily dose for seven days. This regimen has been shown to significantly reduce prostate volume within a short period. Studies have demonstrated that a 40% reduction in prostate size can be achieved within 14 days, with the therapeutic effects lasting for up to six months. This makes Ypozane for Dogs an effective and convenient solution for managing benign prostatic hypertrophy.

VETERINARY PRESCRIPTION REQUIRED

5mg Vetoryl Capsules are used in the treatment of Cushing's syndrome in dogs. Vetoryl may be used for treatment of both pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs.

Vetoryl 5mg is a synthetic steroid that behaves like an agonist at the glucocorticoid receptor, but also has a partial dependency on the mineralocorticoid receptor. This allows Vetoryl to target both pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs.

VET PRESCRIPTION REQUIRED

5mg Vetoryl Capsules are used in the treatment of Cushing's syndrome in dogs. Vetoryl may be used for treatment of both pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs. VET PRESCRIPTION REQUIRED

You've searched for a Human Drug. We can sell human medication for veterinary use by phone on receipt of a signed prescription from your Vet. Please call us on 01234 783113 to order any Human medications for your Pet

Zycortal for Dogs is a prescription-only veterinary medicine used in the long-term management of Addison’s disease (hypoadrenocorticism) in dogs. Addison’s disease is a hormonal disorder in which the adrenal glands do not produce enough steroid hormones for normal day-to-day function. In many dogs, the key deficiency is the mineralocorticoid hormone aldosterone, which helps control sodium and potassium levels and supports fluid balance and blood pressure.

Zycortal replaces mineralocorticoid activity to help stabilise electrolytes and hydration under veterinary monitoring.

How Zycortal works

The active ingredient in Zycortal is desoxycortone pivalate (DOCP). DOCP is a long-acting mineralocorticoid given as an injection under the skin. The dose and timing are set by the prescribing vet and adjusted using follow-up blood tests.

In a healthy dog, aldosterone acts mainly on the kidneys. It encourages sodium retention and potassium excretion. Water follows sodium, helping to maintain blood volume and circulation. When aldosterone is low, sodium can drop and potassium can rise. These electrolyte changes can contribute to dehydration, low blood pressure, weakness, and changes in heart rhythm.

DOCP mimics the missing mineralocorticoid effects. By supporting sodium retention and potassium excretion, it helps bring electrolytes back towards a normal range. Many dogs show better energy, appetite, and hydration once electrolytes stabilise, and gastrointestinal signs may improve if they were linked to the hormonal imbalance.

Zycortal does not replace cortisol. Some dogs with Addison’s disease also need a separate glucocorticoid medicine, such as prednisolone, alongside Zycortal.

VETERINARY PRESCRIPTION REQUIRED.